CRVS Competitors & Alternatives
Compare Corvus Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
CRVS
Main Stock$14.01
Tradestie Score
47
Market Cap
$540.97M
Analyst Upside
+136.6%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$60.60
|
$1.17B | - | 56 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$20.72
|
$1.15B | 3.3 | 47 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$18.68
|
$1.14B | - | 56 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$13.36
|
$1.14B | - | 55 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$27.81
|
$1.13B | - | 51 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$5.94
|
$1.12B | - | 50 | Compare |
|
NKTR
Nektar Therapeutics
|
$72.88
|
$1.12B | - | 57 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$311.48
|
$1.12B | - | 52 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$9.34
|
$1.09B | - | 46 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$10.01
|
$1.05B | 72.0 | 43 | Compare |
More CRVS Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry